A B S T R A C T Effects of human fibroblast (,) or leukocyte (a) interferon (IFN) on differentiations of a human histiocytic lymphoma-derived cell line (U937) or promyelocytic leukemia-derived cell line (HL-60) were studied. When cultured with ,B-IFN (400-1,000 U/ml), U937 cells showed gross morphologic and microscopic changes consisting of clumping, increased cytoplasmic-to-nuclear ratio, enhanced prominence of cytoplasmic granules, and membrane ruffling. After culture with #l-IFN, the number of U937 cells reactive with B43.4.1 monoclonal antibody, which is specific for human monocytes, natural killer cells, and neutrophils, increased from <10% of U937 cells to 47%. ,B-IFN treatment also enhanced antibody-dependent cellular cytotoxicity against chicken erythrocytes by U937 cells. The same morphologic, phenotypic, and functional changes were also observed when U937 were treated with recombinant or natural a-IFN. The effects of a-IFN were totally abolished by anti-a-IFN serum. In contrast, HL-60, which differentiates toward cells of the monocyte lineage in response to phorbol 12-myristate 13-acetate (based on the above criteria), and toward granulocytes in response to dimethyl sulfoxide, did not differentiate when cultured with a-or ,B-IFN. No consistent relationship between induction of differentiation and changes in phospholipid methylation were observed.
INTRODUCTION
In addition to its antiviral properties, the effects of interferon (IFN)' on proliferation of normal or transReceived for publication 2 April 1982 and in revised form 7 February 1983. 1 Abbreviations used in this paper: ADCC, antibody-dependent cell cytotoxicity; CRBC, chicken erythrocytes; DMSO, dimethyl sulfoxide; IFN, interferon; PMA, phorbol 12 -myristate 13-acetate. formed cells and on the function of immunocompetent cells have been extensively studied (1) . IFN, like a variety of other agents, is also reported to affect differentiation. For example, IFN may either block (2) or promote (3) dimethyl sulfoxide (DMSO)-stimulated hemoglobin production in Friend erythroleukemia cells, inhibit insulin-dependent differentiation of 3T3 cells into adipocytes (4) , or enhance differentiation of mouse macrophages (5) .
In human systems, the delay of maturation of monocytes into macrophages by IFN (6) and enhancement of pokeweed mitogen-induced B cell differentiation at low concentrations of IFN and inhibition at high concentration (7) have been reported. Here, we describe differentiation of a human monocyte-like neoplastic cell line after culture with fibroblast or leukocyte IFN and compare its effects with those of other agents known to influence differentiation.
METHODS
Cells. U937 (a monocytelike cell line derived from a patient with histiocytic lymphoma (8) , HL-60 (9) , and K562 (10) (human myeloid leukemia-derived cell lines) were maintained as suspension cultures in complete medium RPMI 1640 (Biofluids, Inc., Rockville, MD) supplemented with 10% fetal bovine serum (Biofluids, Inc.), 2 mM glutamine, 100 U/ml penicillin, 100 Ag/ml streptomycin, 50 ug/ ml gentamicin (NIH Media Unit), and 10 mM Hepes (Microbiological Associates, Walkersville, MD). Medium was changed on alternate days to maintain a cell density of -2 x 105/ml.
Peripheral blood mononuclear cells were separated by Ficoll-Hypaque gradient centrifugation (11) (17) .
Phospholipid methylation assay. Phospholipid methylation was measured by the incorporation of [3H]methionine into chloroform-methanol extractable lipids of intact cells (18) . Briefly, cells were incubated at 37°C in 5% CO2 at 5 X 106/ml in a final volume of 0.4 ml of RPMI 1640 with 2% fetal bovine serum and 400 pmol [methyl-3H]methionine (sp act 80 Ci/mmol, New England Nuclear). The reaction was stopped by removing the medium and adding 0.5 ml of 10% cold trichloroacetic acid containing 10 mM methionine. The 27,000-g pellet was washed twice, then extracted with chloroform-methanol 2:1, and washed with methanol/ 0.1 M KCI (1:1) . An aliquot of the chloroform phase was removed and counted in a ,B-counter. The remaining chloroform phase was dried over sodium sulfate, evaporated to dryness, and separated by thin-layer chromatography on silica gel G with a mobile phase of chloroform/methanol/ acetic acid/water (50:25:7:3).
RESULTS
Morphology and growth patterns. When U937 cells were cultured in the presence of IFN (400-1,000 U/ml), DMSO (1% vol/vol), or PMA (6-30 nM), gross morphologic changes consisting of clumping of cells and adherence to the plastic surfaces were observed. These were similar to those changes observed after exposure of U937 cells to supernatants of mixed lymphocyte cultures (19) . These effects were most prominent in the presence of PMA, where they were seen within 1 d of culture; 90% of U937 cells formed clumps after 6-7 d of culture with PMA (30 nM). The effects of IFN or DMSO were more subtle and variable during the initial days of culture, but after 6-7 d of culture, 30-50% of ,B-IFN (1,000 U/ml)-treated cells and 40-50% of DMSO-treated cells showed clumping.
Treatment with each of these agents resulted in slower growth of U937 cells (Fig. 1) . In the presence of inducers, cell proliferation was inhibited 76% by PMA and 42% by IFN after 7 d of culture. Cultured U937 cells always retained >90% viability.
When cells were examined microscopically, differences were also apparent within 1 d in PMA-treated cultures. IFN-treated cells exhibited identical changes but were maximal on day 7. As shown in Fig. 2 , differentiated cells were larger and were characterized by increased cytoplasmic/nuclear ratio, paler cytoplasm, more prominent granules, a greater degree of vacuolization in the cytoplasm, and ruffled plasma membranes. The number of cells in mitosis decreased (not shown) and occasional multinucleate giant cells were encountered (Fig. 2, C and D (Table I) . Similar experiments were performed in parallel using HL-60, since differentiation of this line towards macrophages by PMA or towards myeloid cells by a variety of other agents has been described. f,-IFN, in doses up to 400 U/ml, induced no expression of B43.4.1 in this cell line, whereas PMA induced B43.4.1 antigen expression (14% at day 7).
Functional analysis of U937 cells. U937 cultured with the various inducers were examined at days 1, 2, 4, and 7 for their cytotoxic activities against antibody-coated CRBC, a function associated with monocytes (Fig. 3) . PMA differentiated U937 cells into cytotoxic effector cells after 1 d of culture, and cells expressed maximum cytotoxic activity as early as day 4. U937 cells stimulated with DMSO expressed B43.4.1 antigen and morphological changes as described above, but demonstrated low cytotoxicity against CRBC. Cells cultured with 400 U ,B-IFN expressed cytotoxicity at day 1, which increased over the course of 7 d.
To substantiate that the effect of IFN was in fact not due to other contaminant proteins, we compared ,B-IFN and homogenous IFLrA with respect to their ability to induce ADCC activity by U937 cells (Fig.  4) . Both had almost the same capacity to differentiate U937 cells into ADCC effector cells. In one experiment, limited by the quantity of antiserum available to us, the effect of ,8-IFN was abolished in a dose-dependent manner by its pretreatment with anti-human ,B-IFN (data not shown). In other experiments, we used a-IFN (natural), because of the availability of specific antiserum in large quantities. a-IFN had almost the same capacity to promote the expression of CRBC-ADCC activity by U937 at 400-1,000 U/ml as other interferon preparations tested. Representative data of three different experiments of U937 cultured for 6 d with IFN are shown in Table II . Anti-a-IFN or sheep serum had slight growth inhibitory activities when tested against U937, but they had no activity in promoting differentiation of U937 as examined by CRBC-ADCC. Expression of CRBC-ADCC induced by ,B-IFN was only partially inhibited by anti-a-IFN to an extent that was also observed with control sheep serum. In contrast, expression of CRBC-ADCC activity and growth-inhibitory activity induced by a-IFN were completely abolished by treatment with specific antiserum (1:100) with less effect at decreasing concentrations.
Activated monocytes as well as peripheral blood mononuclear cells are known to be cytotoxic to erythrocytes (20) . Therefore, the specificity of the ADCC activity by U937 cells cultured with or without inducers was examined. In a 4-h 51Cr-release assay, cells cultured with ,-IFN or PMA did not express cytotoxic activity without antibody (Fig. 5) .
Spontaneous cytotoxic activity against K562 was examined. We observed no activity by U937 cells and HL-60 cells after cultivation for 4 Day of Culture (24) , an enzyme known to be induced by IFN treatment, in extracts of IFN-treated HL-60 or U937 cells (A. Schmidt. Manuscript submitted for publication). This indicates that IFN can bind to and act on HL-60 cells, although, for as yet undetermined reasons, differentiation is not induced.
Our findings raise the possibility that some of the in vivo effects of IFN administration, including its antineoplastic properties, might be attributable to its influences on differentiation. For example, a report of the disappearance of symptoms after ,B-IFN treatment of a patient with Hodgkin's disease (25) , which is assumed to be of histocytic-monocytic origin, might be attributed to these effects.
Differentiation of a Human Monocyte Cell Line by Interferon (32) . We could not observe changes in the functional activity of methyltransferase by any of three inducers that correlate with the ability of cell-line cells to undergo differentiation (or not) in response to IFN, as well as the other agents, in either U937 or HL-60. The discrepancy between our data using PMA and those of others may be ascribed to the different (i.e., lower) doses we used, since in our hands doses above 100 nM were often toxic, and to possible differences in the concentration of methionine in the media used, since we have shown the dependence of effects on lipid nmethylation on methionine concentration (33) . However, at concentrations of inducers (notably IFN, but also TPA) where we could observe similar morphological and functional changes, indicative of differentiation, methyltransferase activity remained almost the same. These findings make less likely the hypothesis that early decreases in phospholipid methylation are associated with commitment to differentiation.
The system described here, where biologically active agents with a potentially wide variety of disparate biochemical effects induced differentiation along different pathways, represents a unique opportunity to investigate the control mechanisms governing these events. We are presently investigating methylation of other cell constituents aside from phospholipids, other aspects of phospholipid metabolism, and pathways involved in regulation of RNA synthesis that could potentially be altered by IFN and other agents which induce differentiation of monocytelike cells.
